Current Headlines

  1. Will The EPA’s Sterilizer Assessment Disrupt The Medical Device Industry?
    11/21/2014

    The Chemical Assessment Advisory Committee (CAAC) of the Environmental Protection Agency’s Science Advisory Board (SAB) met recently to evaluate the agency’s Integrated Risk Information System (IRIS) draft assessment of the carcinogenic effects of ethylene oxide (EO). The final draft conclusion on the risks of EO could have major implications for medical device makers.

  2. Smith & Nephew Sells U.K. Facility, Closes Another, Cuts 108 Jobs
    11/21/2014

    Smith & Nephew (S&N) recently announced the sale of its Gilberdyke facility in the U.K., along with its nets and foams product portfolio and manufacturing assets, to DelStar Inc., a unit of SWM. The agreement is expected to close by the end of the year and to be accretive starting in 2015. Other terms of the deal were not disclosed.

  3. “NanoFlares” Illuminate Individual Cancer Cells
    11/20/2014

    Recently, a team from Northwestern University developed nanoparticles with a built-in fluorescent tag that are capable of identifying genetic biomarkers specific to cancer. Deemed “NanoFlares,” these particles operate inside the cell and can identify cancer cells in the bloodstream, potentially providing an early warning of metastasis.

  4. Enhancing Ebola Surveillance With Faster, More Accurate Genome Sequencing
    11/20/2014

    A new method of genomic sequencing has been developed that could provide efficient and affordable Ebola surveillance for West African nations. The process enables shorter test times and allows viruses to be tracked in populations where it may be spreading. 

  5. Brazil’s ANVISA Seeking Industry Feedback Following Manufacturing Inspections
    11/20/2014

    Brazil’s medical device regulatory body, the Agência Nacional de Vigilância Sanitária (ANVISA), recently announced that it will now be accepting industry feedback following Brazilian Good Manufacturing Practice (BGMP) inspections.

  6. Dual-Action Nanoparticle Allows Fluorescence Imaging And MRI
    11/20/2014

    A hybrid nanoparticle has been developed that is compatible with both fluorescence imaging and magnetic resonance imaging (MRI). The new agent may allow a better real-time understanding of tumor biochemistry and drug delivery.

  7. Novartis, QIAGEN Sign Deal To Develop Companion Diagnostics
    11/20/2014

    QIAGEN, a provider of sample and assay technologies, recently signed an agreement with Swiss pharmaceutical firm Novartis to develop and commercialize companion diagnostics for Novartis’ existing and future portfolio of drugs. Financial terms of the deal were not made available.

  8. Qosina Swabbable Pre-Slit Transfer Valve
    11/20/2014

    Qosina is pleased to announce the addition of a new Swabbable Pre-Slit Transfer Valve (80191).

  9. ITL Partners With QuantuMDx To Further Develop The Q-POC Handheld Lab For 15 Minute DNA-Based Diagnosis
    11/20/2014

    Integrated Technologies Ltd is working with QuantuMDx to develop their Q-POC handheld point-of-care testing device.

  10. Medtronic, Covidien Set Meetings For Shareholder Approval
    11/19/2014

    After securing permission during a hearing before the Irish High Court, Medtronic Inc. and Covidien plc announced that they will be holding special meetings with their respective shareholders. The meetings will be held so shareholders can vote for approval on the impending merger.

Newsletter Signup
Newsletter Signup
Get the latest medical device industry news, insights, and analysis delivered to your inbox.
By clicking Sign Me Up, you agree to our Terms and that you have read our Privacy Policy.